GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
Europe - FRA:GXI - DE000A0LD6E6 - Common Stock
25.48 EUR
-0.5 (-1.92%)
Overall GXI gets a fundamental rating of 3 out of 10. We evaluated GXI against 18 industry peers in the Life Sciences Tools & Services industry. GXI may be in some trouble as it scores bad on both profitability and health. GXI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year GXI was profitable.
In the past year GXI had a positive cash flow from operations.
In the past 5 years GXI has always been profitable.
Each year in the past 5 years GXI had a positive operating cash flow.
1.2 Ratios
The Return On Assets of GXI (0.50%) is worse than 88.89% of its industry peers.
GXI has a worse Return On Equity (1.67%) than 88.89% of its industry peers.
The Return On Invested Capital of GXI (2.79%) is worse than 88.89% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GXI is in line with the industry average of 7.57%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROIC | 2.79% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
GXI's Profit Margin of 1.04% is on the low side compared to the rest of the industry. GXI is outperformed by 88.89% of its industry peers.
GXI's Profit Margin has been stable in the last couple of years.
GXI has a Operating Margin of 5.99%. This is amonst the worse of the industry: GXI underperforms 88.89% of its industry peers.
In the last couple of years the Operating Margin of GXI has grown nicely.
GXI has a worse Gross Margin (26.89%) than 77.78% of its industry peers.
In the last couple of years the Gross Margin of GXI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GXI is destroying value.
Compared to 1 year ago, GXI has about the same amount of shares outstanding.
The number of shares outstanding for GXI has been increased compared to 5 years ago.
Compared to 1 year ago, GXI has a worse debt to assets ratio.
2.2 Solvency
GXI has an Altman-Z score of 0.95. This is a bad value and indicates that GXI is not financially healthy and even has some risk of bankruptcy.
GXI has a Altman-Z score of 0.95. This is amonst the worse of the industry: GXI underperforms 83.33% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that GXI has dependencies on debt financing.
GXI has a worse Debt to Equity ratio (1.22) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.95 |
ROIC/WACC0.36
WACC7.65%
2.3 Liquidity
A Current Ratio of 0.98 indicates that GXI may have some problems paying its short term obligations.
With a Current ratio value of 0.98, GXI is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
A Quick Ratio of 0.52 indicates that GXI may have some problems paying its short term obligations.
The Quick ratio of GXI (0.52) is worse than 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
GXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.08%.
GXI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
Looking at the last year, GXI shows a quite strong growth in Revenue. The Revenue has grown by 11.83% in the last year.
GXI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.90% yearly.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
3.2 Future
Based on estimates for the next years, GXI will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.98% on average per year.
GXI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.51% yearly.
EPS Next Y-18.32%
EPS Next 2Y1.28%
EPS Next 3Y7.45%
EPS Next 5Y8.98%
Revenue Next Year17.05%
Revenue Next 2Y11.28%
Revenue Next 3Y9.65%
Revenue Next 5Y8.51%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 6.91, the valuation of GXI can be described as very cheap.
Based on the Price/Earnings ratio, GXI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of GXI to the average of the S&P500 Index (26.13), we can say GXI is valued rather cheaply.
GXI is valuated cheaply with a Price/Forward Earnings ratio of 5.31.
GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.35. GXI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.91 | ||
| Fwd PE | 5.31 |
4.2 Price Multiples
94.44% of the companies in the same industry are more expensive than GXI, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.37 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.28%
EPS Next 3Y7.45%
5. Dividend
5.1 Amount
With a yearly dividend of 0.14%, GXI is not a good candidate for dividend investing.
In the last 3 months the price of GXI has falen by -44.34%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
GXI's Dividend Yield is slightly below the industry average, which is at 0.72.
With a Dividend Yield of 0.14, GXI pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.14% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
GXI pays out 10.12% of its income as dividend. This is a sustainable payout ratio.
GXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP10.12%
EPS Next 2Y1.28%
EPS Next 3Y7.45%
FRA:GXI (11/5/2025, 7:00:00 PM)
25.48
-0.5 (-1.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners92.48%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap880.08M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts72.17
Price Target40.1 (57.38%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.14% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-39.27%
PT rev (3m)-40.2%
EPS NQ rev (1m)-30.91%
EPS NQ rev (3m)-30.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.45%
Revenue NQ rev (1m)-9.83%
Revenue NQ rev (3m)-9.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.91 | ||
| Fwd PE | 5.31 | ||
| P/S | 0.39 | ||
| P/FCF | N/A | ||
| P/OCF | 3.47 | ||
| P/B | 0.63 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.37 |
EPS(TTM)3.69
EY14.48%
EPS(NY)4.8
Fwd EY18.84%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY28.82%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROCE | 3.76% | ||
| ROIC | 2.79% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 5.89% | ||
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.4 | ||
| Cap/Depr | 134.54% | ||
| Cap/Sales | 15.12% | ||
| Interest Coverage | 1.65 | ||
| Cash Conversion | 65.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 0.95 |
F-Score4
WACC7.65%
ROIC/WACC0.36
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-18.32%
EPS Next 2Y1.28%
EPS Next 3Y7.45%
EPS Next 5Y8.98%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year17.05%
Revenue Next 2Y11.28%
Revenue Next 3Y9.65%
Revenue Next 5Y8.51%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year113.62%
EBIT Next 3Y38.46%
EBIT Next 5Y24.57%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%
GERRESHEIMER AG / GXI.DE FAQ
What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.
What is the valuation status of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.
How profitable is GERRESHEIMER AG (GXI.DE) stock?
GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.
How financially healthy is GERRESHEIMER AG?
The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.
What is the expected EPS growth for GERRESHEIMER AG (GXI.DE) stock?
The Earnings per Share (EPS) of GERRESHEIMER AG (GXI.DE) is expected to decline by -18.32% in the next year.